Kymera Therapeutics (KYMR) Misses Q3 EPS by 18c
Kymera Therapeutics (NASDAQ: KYMR) reported Q3 EPS of ($0.94), $0.18 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Kymera Therapeutics (KYMR) click here.
Kymera Therapeutics (NASDAQ: KYMR) reported Q3 EPS of ($0.94), $0.18 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Kymera Therapeutics (KYMR) click here.